NDC00781-3209-95: CEFTRIAXONE SODIUM.
The CEFTRIAXONE SODIUM is a the manufacturer industrial component. Key specifications include physical_form: POWDER, administration: INTRAMUSCULAR OR INTRAVENOUS, primary_container_type: VIAL, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 10, primary_container_content_quantity: 2.000 GRAMS OF ACTIVE INGREDIENT G. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-229-3149, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| physical_form | POWDER |
| administration | INTRAMUSCULAR OR INTRAVENOUS |
| special_features | 20 ML CAPACITY VIAL. STORAGE PRIOR TO RECONSTITUTION: STORE AT 20-25 DEG C (68-77 DEG F) (SEE USP CONTROLLED ROOM TEMPERATURE) PROTECT FROM LIGHT. DEGC |
| primary_container_type | VIAL |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 10 |
| primary_container_content_quantity | 2.000 GRAMS OF ACTIVE INGREDIENT G |
| active_medicament_medicinal_strength | 2.000 GRAMS CEFTRIAXONE EQUIVALENT G |
| part_name_assigned_by_controlling_agency | CEFTRIAXONE SODIUM STERILE USP 2GM VIAL 10S |
| NSN | 6505-01-229-3149 |
| ADMINISTRATION | INTRAMUSCULAR OR INTRAVENOUS |
| PRIMARY CONTAINER CONTENT QUANTITY | 2.000 GRAMS OF ACTIVE INGREDIENT G |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | VIAL |
| PHYSICAL FORM | POWDER |
| SPECIAL FEATURES | 20 ML CAPACITY VIAL. STORAGE PRIOR TO RECONSTITUTION: STORE AT 20-25 DEG C (68-77 DEG F) (SEE USP CONTROLLED ROOM TEMPERATURE) PROTECT FROM LIGHT. DEGC |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CEFTRIAXONE SODIUM STERILE USP 2GM VIAL 10S |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 2.000 GRAMS CEFTRIAXONE EQUIVALENT G |
| TOTAL PRIMARY CONTAINER QUANTITY | 10 |